Concepedia

Adam J. Schoenfeld

AJ

58

Publications

4.7K

Citations

34

H-Index

1990

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Dana-Farber Cancer Institute

Harvard University

Massachusetts General Hospital

Adam J. Schoenfeld is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and lung cancer.

ORCID

Top concepts

Publications per year

1990–2025

58

Publications

58

Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib

Adam J. Schoenfeld, Kathryn C. Arbour, Hira Rizvi et al. · Annals of Oncology · 2019 · 401 citations · Full text

, , +9

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227

Julie R. Brahmer, Jong-Seok Lee, Tudor–Eliade Ciuleanu et al. · Journal of Clinical Oncology · 2022 · 345 citations · Full text

SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas

Natasha Rekhtman, Joseph Montecalvo, Jason C. Chang et al. · Journal of Thoracic Oncology · 2019 · 292 citations · Full text

COVID-19 in patients with lung cancer

Jie Luo, Hira Rizvi, Isabel R. Preeshagul et al. · Annals of Oncology · 2020 · 267 citations · Full text

, , +3

The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung Cancer

Adam J. Schoenfeld, Chai Bandlamudi, Jessica A. Lavery et al. · Clinical Cancer Research · 2020 · 265 citations · Full text

Rows per page

1–5 of 58